News

Valneva Submits Chikungunya Vaccine Marketing Application to EMA and Announces CHMP Accelerated Assessment

Innovatives Forschungsprojekt entwickelt Hightech-Pflaster zur Früherkennung von Nierenerkrankungen

Klimastrategie als Fahrplan für klimaneutrales Gesundheitswesen vorgestellt

Skin cancer diagnoses using AI are as reliable as those made by medical experts

HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Medical Oncology Congress 2023

Gefälschte Medikamente können töten

Newly discovered compound blocks signalling pathway of immune response

New insights into the genetics of the common octopus: genome at the chromosome level decoded

Nuklearmedizin bietet Peptidrezeptor-basierte Therapie

HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences

Steriles Laborequipment aus dem 3D-Drucker

CED-Nursing Austria unterstützt vorbildliche Pflegeprojekte mit 5.000 Euro

CED-Nursing Austria unterstützt vorbildliche Pflegeprojekte mit 5.000 Euro

Österreichische Adipositas Gesellschaft veröffentlicht wegweisendes Konsensuspapier zur Diagnose und Behandlung von Adipositas

Inaugural BIOTECH SUMMIT AUSTRIA Sets the Agenda for Emerging Biotech Innovation

Wechsel in der Geschäftsführung im Boehringer Ingelheim Regional Center Vienna

Art with DNA – Digitally creating 16 million colors by chemistry

Successful Phase 1 Trial Demonstrates Excellent Safety and Substantial Efficacy of Viral Vector delNS/E6E7 in Patients Infected with HPV16 and Cervical Lesions

Marinomed Biotech AG resumes Nice & Green Convertible Notes Funding Program with reduced volume

AstraZeneca PrimeTime 2023: Nachhaltigkeit im Gesundheitswesen im Fokus